Market Cap 604.13M
Revenue (ttm) 35.28M
Net Income (ttm) -169.03M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -479.11%
Debt to Equity Ratio 0.00
Volume 625,100
Avg Vol 355,856
Day's Range N/A - N/A
Shares Out 69.20M
Stochastic %K 73%
Beta 1.40
Analysts Strong Sell
Price Target $28.50

Latest News on BCYC

Bicycle Therapeutics Is Looking Increasingly Attractive

Aug 20, 2024, 7:37 AM EDT - 8 months ago

Bicycle Therapeutics Is Looking Increasingly Attractive


2 More Potential Biotech Buyout Targets

Mar 25, 2024, 1:07 PM EDT - 1 year ago

2 More Potential Biotech Buyout Targets

AZN BMY EXEL LLY MRK NVS TAK


Bicycle Therapeutics to Host R&D Day on December 14

Nov 30, 2023, 7:00 AM EST - 1 year ago

Bicycle Therapeutics to Host R&D Day on December 14